Research

A generic cardiovascular drug called mexiletine, initially developed to treat heart rhythm abnormalities, appears to hold some potential for treating muscle stiffness and other symptoms of non-dystrophic myotonias (NDMs),

Antisense oligonucleotides – short segments of genetic material designed to target specific areas of a gene

The new approach could have implications for many genetic diseases.

ROSEVILLE, CA (January 25, 2012): Myotonic is pleased to announce its largest-ever round of Fund-A-Fellow postdoctoral fellowship research grant awards.